Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;60(2):287-295.
doi: 10.1007/s00125-016-4150-x. Epub 2016 Nov 4.

Peptide serum markers in islet autoantibody-positive children

Affiliations

Peptide serum markers in islet autoantibody-positive children

Christine von Toerne et al. Diabetologia. 2017 Feb.

Abstract

Aims/hypothesis: We sought to identify minimal sets of serum peptide signatures as markers for islet autoimmunity and predictors of progression rates to clinical type 1 diabetes in a case-control study.

Methods: A double cross-validation approach was applied to first prioritise peptides from a shotgun proteomic approach in 45 islet autoantibody-positive and -negative children from the BABYDIAB/BABYDIET birth cohorts. Targeted proteomics for 82 discriminating peptides were then applied to samples from another 140 children from these cohorts.

Results: A total of 41 peptides (26 proteins) enriched for the functional category lipid metabolism were significantly different between islet autoantibody-positive and autoantibody-negative children. Two peptides (from apolipoprotein M and apolipoprotein C-IV) were sufficient to discriminate autoantibody-positive from autoantibody-negative children. Hepatocyte growth factor activator, complement factor H, ceruloplasmin and age predicted progression time to type 1 diabetes with a significant improvement compared with age alone.

Conclusion/interpretation: Distinct peptide signatures indicate islet autoimmunity prior to the clinical manifestation of type 1 diabetes and enable refined staging of the presymptomatic disease period.

Keywords: Autoantibody-positive; Autoimmunity; BABYDIAB/BABYDIET; LC-MS/MS; Progression time; Risk score; Selected reaction monitoring; Targeted proteomic; Type 1 diabetes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Diabetes Complications. 2004 Jul-Aug;18(4):193-7 - PubMed
    1. Clin Chem. 2010 Feb;56(2):291-305 - PubMed
    1. Diabetes. 2010 Jan;59(1):200-9 - PubMed
    1. Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):429-38 - PubMed
    1. Diabetologia. 2012 Jul;55(7):1926-36 - PubMed

Publication types

MeSH terms

LinkOut - more resources

-